title: [Biological therapy of inflammatory bowel disease].
authors.forename: L B
authors.initials: LB
authors.lastname: Lazebnik
authors.forename: A I
authors.initials: AI
authors.lastname: Parfenov
authors.forename: O V
authors.initials: OV
authors.lastname: Kniazev
authors.forename: A G
authors.initials: AG
authors.lastname: Konopliannikov
authors.forename: V E
authors.initials: VE
authors.lastname: Sagynbaeva
authors.forename: M V
authors.initials: MV
authors.lastname: Iakovleva
authors.forename: T A
authors.initials: TA
authors.lastname: Astrelina
authors.forename: I N
authors.initials: IN
authors.lastname: Ruchkina
authors.forename: P L
authors.initials: PL
authors.lastname: Shcherbakov
authors.forename: I E
authors.initials: IE
authors.lastname: Trubitsyna
authors.forename: T M
authors.initials: TM
authors.lastname: Tsaregorodtseva
authors.forename: R B
authors.initials: RB
authors.lastname: Gudkova
authors.forename: V A
authors.initials: VA
authors.lastname: Rogozina
authors.forename: B Z
authors.initials: BZ
authors.lastname: Chikunova
authors.forename: S G
authors.initials: SG
authors.lastname: Khomeriki
authors.forename: Z F
authors.initials: ZF
authors.lastname: Mikhaĭlova
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D000069285:Infliximab; D045164:Mesenchymal Stem Cell Transplantation; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab